Aimei Health Technology Co., Ltd. (AFJK) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aimei Health Technology Co., Ltd. (AFJK:NASDAQ), powered by AI.

Current Price
$67.86
P/E Ratio
242.4
Market Cap
619M
Sector
Financial Services
What is the Aimei Health Technology Co., Ltd. stock price forecast?

Aimei Health Technology Co., Ltd. is currently trading at $67.86. View real-time AI analysis on Alpha Lenz.

What is Aimei Health Technology Co., Ltd. insider trading activity?

View the latest insider trading data for Aimei Health Technology Co., Ltd. on Alpha Lenz.

What is Aimei Health Technology Co., Ltd.'s P/E ratio?

Aimei Health Technology Co., Ltd.'s P/E ratio is 242.4.

Aimei Health Technology Co., Ltd.

NASDAQ · AFJK
$67.86
Ask about Aimei Health Technology Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Aimei Health Technology Co., Ltd. trades at a P/E of 242.4 (premium valuation) with modest ROE of 3.6%.

Ask for details

Company Overview

Aimei Health Technology Co., Ltd. specializes in the research, development, and production of advanced health technology solutions. The company's primary focus is on creating innovative medical devices and wellness products that are aimed at improving patient care and enhancing the quality of health services. Aimei Health Technology operates across various sectors in the healthcare industry, including hospitals, clinics, and personal healthcare products targeted at individual consumers. Its extensive product line includes diagnostic equipment, therapeutic devices, and digital health platforms that utilize cutting-edge technology. As a key player in the health technology market, Aimei Health Technology Co., Ltd. is influential in driving advancements in healthcare delivery. The company's strong emphasis on research and development underscores its role in fostering technological innovation in health management. As global health demands continue to grow, Aimei Health Technology serves as a vital contributor to the modernization and efficiency of healthcare systems, addressing diverse medical needs with precision and efficacy.

CEOMr. Junheng Xie
SectorFinancial Services
IndustryShell Companies
0

Company Statistics

FY 2024

Profile

$618.55MMarket Cap
$0.00Revenue
0.00Shares Out
0Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

242.36P/E
8.55P/B
N/AEV/Sales
-581.10EV/EBITDA
-920.06P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

3.54%ROA
3.59%ROE
-1.48%ROIC

Financial Health

$28.21KCash & Cash Equivalents
$1.48MNet Debt
2.08%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

Aimei Health Technology Co., Ltd. trades at a P/E of 242.4 (premium valuation) with modest ROE of 3.6%.

Ask for details

Frequently Asked Questions

Aimei Health Technology Co., Ltd. (ticker: AFJK) is a company listed on NASDAQ in the Financial Services sector (Shell Companies). Market cap is $619M.

The current price is $67.86 with a P/E ratio of 242.36x and P/B of 8.55x.

ROE is 3.59%.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Aimei Health Technology Co., Ltd. (Financial Services) Stock Forecast & Analysis $67.86 | Alpha Lenz